Literature DB >> 23830203

Immunoproteomic characterization of Ambrosia artemisiifolia pollen allergens in canine atopic dermatitis.

Jana Ognjenovic1, Natalija Milcic-Matic, Katarina Smiljanic, Olga Vuckovic, Lidija Burazer, Nikola Popovic, Dragana Stanic-Vucinic, Tanja Cirkovic Velickovic.   

Abstract

Canine atopic dermatitis (CAD) is an immune system disorder that affects 10-15% of the canine population. Short ragweed (Ambrosia artemisiifolia) pollen represents one of the major seasonal sources of allergenic pollen proteins in Europe, particularly in the Pannonian valley of the Balkan region. In Serbia, about 66% of atopic dogs showed a positive intradermal skin test with its pollen extract, which is second to house dust mites. Therefore, characterization of Ambrosia artemisiifolia pollen components, in terms of defining major and minor allergens that induce clinically manifested allergic reaction in dogs, is important for valid diagnosis and efficient therapy. This study has, for the first time, characterized and identified major Ambrosia artemisiifolia allergens in CAD, using an immunoproteomic approach. To assess the prevalence of specific IgE in electrophoretically separated ragweed pollen proteins, individual reactivity of sera from dogs with CAD was analyzed and compared to the reactivity of sera from healthy dogs in the non-reducing conditions, which were found optimal for specific canine IgE detection. A specific IgE band (38 kDa) was recognized as the most dominant allergen in CAD, occurring in 81% of positive dog's sera. 2-D immunoblotting followed by a mass spectrometry peptide fingerprint analyses with pooled canine and human atopic sera, revealed that 38 kDa major Ambrosia atremisiifolia allergens in CAD were all five isoallergens of the Amb a 1 group (antigen E), including the previously named Amb a 2 (antigen K). In contrast to canine sera, human atopic sera also recognized lower mass allergens such as the β fragment of Amb a 1 and profilins (Amb a 8 variants). The most prominent ragweed proteins in CAD, represent, as in humans, variants of all five isoallergens of the Amb a 1 group (pectate lyase): Amb a 1.0101 and its natural variant E1XUL2, Amb a 1.0202, 1.0304, 1.0402 and the natural variant of Amb a 1.0501, E1XUM0, as well as the α fragment of pollen allergen Amb a 1.0201.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AD; Amb a 1 allergens; Ambrosia artemisiifolia pollen; CAD; CBB; Canine atopic dermatitis; Coomassie brilliant blue; Dog; ID; IDST; Immunoproteomics; LTQ; MS; PAA; PNU; Short ragweed; TTBS; Tris buffered saline with 0.1% Tween 20 (pH 7.4); atopic dermatitis; canine atopic dermatitis; internal diameter; intradermal skin test; linear ion trap with quadrupole mass filter; mass spectroscopy; nLC–MS/MS; nano-liquid chromatography coupled to tandem mass spectroscopy; polyacrylamide; protein nitrogen unit

Mesh:

Substances:

Year:  2013        PMID: 23830203     DOI: 10.1016/j.vetimm.2013.06.005

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  3 in total

1.  House-dust mite allergy: mapping of Dermatophagoides pteronyssinus allergens for dogs by two-dimensional immunoblotting.

Authors:  Luís Miguel Lourenço Martins; Andreia Grilo Marques; Luísa Maria Dotti Silva Pereira; Ana Goicoa; Saul José Semião-Santos; Ofélia Pereira Bento
Journal:  Postepy Dermatol Alergol       Date:  2015-03-30       Impact factor: 1.837

2.  Repeated-dose toxicity of common ragweed on rats.

Authors:  Tivadar Kiss; Andrea Szabó; Gábor Oszlánczi; Anita Lukács; Zoltán Tímár; László Tiszlavicz; Dezső Csupor
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

3.  Allergy to grass pollen: mapping of Dactylis glomerata and Phleum pratense allergens for dogs by two-dimensional immunoblotting.

Authors:  Luís Miguel Lourenço Martins; Andreia Grilo Marques; Luísa Maria Dotti Silva Pereira; Saul José Semião-Santos; Ofélia Pereira Bento
Journal:  Postepy Dermatol Alergol       Date:  2017-02-07       Impact factor: 1.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.